Implementation of Reverse Transcriptase PCR Testing for Severe Acute Respiratory Syndrome Coronavirus 2 under the US Food and Drug Administration Emergency Use Authorization.
Título
Implementation of Reverse Transcriptase PCR Testing for Severe Acute Respiratory Syndrome Coronavirus 2 under the US Food and Drug Administration Emergency Use Authorization.
Autor
Joel A Lefferts, Samantha F Allen, Heather B Steinmetz, Gregory J Tsongalis
Fecha
2021
Identificador
10.1093/clinchem/hvaa278
Fuente
Clinical chemistry
Archivos
Colección
Citación
Joel A Lefferts, Samantha F Allen, Heather B Steinmetz, Gregory J Tsongalis, “Implementation of Reverse Transcriptase PCR Testing for Severe Acute Respiratory Syndrome Coronavirus 2 under the US Food and Drug Administration Emergency Use Authorization.,” SOCICT Open, consulta 18 de abril de 2026, https://socictopen.socict.org/items/show/8351.
Position: 14062 (21 views)